Some patients can regain weight after stopping GLP-1 medication, especially without a maintenance plan
PLos One 9(7):e100627 Jiang Q, Jiang G, Shi KQ, Cai H, Wang YX, Zheng MH (2013) Oral acetyl-L-carnitine treatment in hepatic encephalopathy: view of evidence-based medicine
Aplicacin en medicina regenerativa: Un estudio piloto realizado en la Universidad de Sel (Kim et al., 2025) explor el uso del GHK-Cu en combinacin con factores de crecimiento plaquetarios (PRP) para el tratamiento de cicatrices de acn atrficas
Berobenatide (PF3944) is an investigational GLP-1 receptor agonist peptide that Pfizer is developing for chronic weight management and obesity-related comorbidities, with a program explicitly designed to support monthly maintenance dosing
These medicines are available as injections given daily or weekly, and some (such as Rybelsus) are available as pills